Patients with severe diabetes rely on insulin injections to control their blood glucose. A study now provides evidence that human cells that normally do not release insulin can be converted into insulin-producing cells that are able to normalize glycaemia in diabetic mice.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Zhou, Q. & Melton, D. A. Nature 557, 351–358 (2018).
Aguayo-Mazzucato, C. & Bonner-Weir, S. Cell Metab. 27, 57–67 (2018).
Bakhti, M., Böttcher, A. & Lickert, H. Nat. Rev. Endocrinol. 15, 155–171 (2019).
Thorel, F. et al. Nature 464, 1149–1154 (2010).
Chera, S. et al. Nature 514, 503–507 (2014).
Furuyama, K. et al. Nature https://doi.org/10.1038/s41586-019-0942-8 (2019).
Matsuoka, T. A. et al. Diabetes 66, 1293–1300 (2017).
Roscioni, S. S., Migliorini, A., Gegg, M. & Lickert, H. Nat. Rev. Endocrinol. 12, 695–709 (2016).
Wang, Y. et al. Mol. Ther. 26, 1327–1342 (2018).
Dorrell, C. et al. Stem Cell Res. 1, 183–194 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Bakhti, M., Lickert, H. Cell makeover for diabetes therapy. Nat Metab 1, 312–313 (2019). https://doi.org/10.1038/s42255-019-0048-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-019-0048-5
This article is cited by
-
Neue Ansätze zur Regeneration der insulinproduzierenden β-Zelle
Die Diabetologie (2022)